tiprankstipranks
Trending News
More News >
Fresenius Medical Care Corp. (FMS)
NYSE:FMS
US Market
Advertisement

Fresenius Medical Care (FMS) Earnings Dates, Call Summary & Reports

Compare
343 Followers

Earnings Data

Report Date
Nov 04, 2025
TBA (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.57
Last Year’s EPS
0.45
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 05, 2025|
% Change Since: 1.72%|
Earnings Call Sentiment|Neutral
The earnings call conveyed a positive outlook with strong revenue and operating income growth, improved cash flow, and strategic initiatives like share buybacks. However, concerns over patient outflows due to a severe flu season, elevated mortality rates, and challenges in U.S. volume growth tempered the overall sentiment.
Company Guidance -
Q3 2025
In the second quarter of 2025, Fresenius Medical Care reported an organic revenue growth of 7%, with contributions from all three operating segments. The FME25+ transformation program delivered EUR 58 million in sustainable savings towards a target of EUR 180 million for the year, and operating income grew by 13%, enhancing margin expansion. Operating cash flow saw a significant increase of 75%, while the net leverage ratio improved to 2.7x, aligning with the target range of 2.5x to 3x. The company confirmed its full-year 2025 outlook, despite anticipating flat to slightly positive same market treatment growth in the U.S. due to higher-than-expected patient outflow from a severe flu season. A share buyback program of EUR 1 billion was announced, with the first tranche planned for August, as part of a strategy to boost shareholder returns.
Strong Organic Revenue Growth
Fresenius Medical Care delivered a robust organic revenue growth of 7% with positive contributions from all three operating segments in the second quarter of 2025.
Significant Operating Income Growth
The company achieved a 13% increase in operating income, indicating strong margin expansion and effective cost management strategies.
Improved Cash Flow and Leverage
Operating cash flow increased by 75%, and the net leverage ratio improved to 2.7x, well within the target range of 2.5x to 3x.
Share Buyback Program Announcement
A EUR 1 billion share buyback program was announced, demonstrating confidence in future growth and commitment to shareholder returns.
Care Enablement Margin Progression
Care Enablement segment showed a significant 79% increase in operating income, advancing within the 2025 target margin band to 8.7%.
Value-Based Care Revenue Growth
Value-Based Care segment realized strong organic revenue growth of 28%, driven by expanded contracting and increased member months.

Fresenius Medical Care (FMS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

FMS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 04, 2025
2025 (Q3)
0.57 / -
0.447
Aug 05, 2025
2025 (Q2)
0.51 / 0.53
0.37839.15% (+0.15)
May 06, 2025
2025 (Q1)
0.43 / 0.48
0.36131.86% (+0.11)
Feb 25, 2025
2024 (Q4)
0.42 / 0.48
0.4760.42% (<+0.01)
Nov 05, 2024
2024 (Q3)
0.38 / 0.45
0.30347.52% (+0.14)
Jul 30, 2024
2024 (Q2)
0.37 / 0.38
0.32217.39% (+0.06)
May 07, 2024
2024 (Q1)
0.28 / 0.36
0.29124.05% (+0.07)
Feb 20, 2024
2023 (Q4)
0.44 / 0.48
0.4564.39% (+0.02)
Nov 01, 2023
2023 (Q3)
0.29 / 0.30
0.403-24.81% (-0.10)
Aug 02, 2023
2023 (Q2)
0.29 / 0.32
0.393-18.07% (-0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FMS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 05, 2025
$24.94$24.42-2.09%
May 06, 2025
$25.14$26.90+7.00%
Feb 25, 2025
$22.87$23.01+0.61%
Nov 05, 2024
$19.67$19.95+1.42%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Fresenius Medical Care Corp. (FMS) report earnings?
Fresenius Medical Care Corp. (FMS) is schdueled to report earning on Nov 04, 2025, TBA (Confirmed).
    What is Fresenius Medical Care Corp. (FMS) earnings time?
    Fresenius Medical Care Corp. (FMS) earnings time is at Nov 04, 2025, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is FMS EPS forecast?
          FMS EPS forecast for the fiscal quarter 2025 (Q3) is 0.57.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis